EODData

FRA, 1YR: IMMUNOVIA AB

06 Feb 2026
LAST:

0.0001

CHANGE:
 0.00
OPEN:
0.0001
HIGH:
0.0001
ASK:
0.0000
VOLUME:
0
CHG(%):
0.00
PREV:
0.0001
LOW:
0.0001
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Feb 260.00010.00010.00010.00010
05 Feb 260.00010.00010.00010.00015.0K
04 Feb 260.00010.00010.00010.00015.0K
03 Feb 260.00010.00010.00010.00015.0K
02 Feb 260.00010.00010.00010.00015.0K
30 Jan 260.00010.00010.00010.00015.0K
29 Jan 260.00050.00050.00050.00055.0K
28 Jan 260.00010.00010.00010.00015.0K
27 Jan 260.00030.00030.00030.00035.0K
26 Jan 260.00010.00010.00010.00015.0K

PROFILE

Name:IMMUNOVIA AB
About:Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Sector:Healthcare
Address:Medicon Village, Lund, Sweden, 223 63
Website:https://www.immunovia.com
ISIN:SE0006091997
LEI:549300KHWL6KK1XGUO81

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:0.06 
PEG Ratio:0.00 
Price to Sales:52.62 
Price to Book:-0.05 
Profit Margin:1.00 
Operating Margin:-80.22 
Return on Assets:-1.17 
Return on Equity:-8.28 
Revenue:86.2K 
Shares:306.08M 
Market Cap:30.6K 

TECHNICAL INDICATORS

MA5:0.000.0%
MA10:0.00100.0%
MA20:0.00300.0%
MA50:0.002,100.0%
MA100:0.018,900.0%
MA200:0.0216,400.0%
RSI14:50.00
WPR14:-100.00 
ATR:0.00 
Week High:0.000.0%
Week Low:0.000.0%
Month High:0.001,400.0%
Month Low:0.0016,400.0%
Year High:0.0880,000.0%
Year Low:0.000.0%

RECENT SPLITS

Date Ratio
03 Feb 20261-100